Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF DECEMBER 01, 2010 FBO #3294
MODIFICATION

R -- "Rapidly-Acting Treatments for Treatment-Resistant Depression (RAPID)" - Solicitation 1

Notice Date
11/29/2010
 
Notice Type
Modification/Amendment
 
NAICS
541712 — Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6101 Executive Boulevard, Room 260 - MSC 8402, Bethesda, Maryland, 20892
 
ZIP Code
20892
 
Solicitation Number
HHSNIHNIMH10024
 
Archive Date
1/28/2011
 
Point of Contact
Marla J. Jacobson, Phone: 3014433775, Bruce E. Anderson, Phone: 3014432234
 
E-Mail Address
jacobsonmj@mail.nih.gov, ba9i@nih.gov
(jacobsonmj@mail.nih.gov, ba9i@nih.gov)
 
Small Business Set-Aside
N/A
 
Description
Request for Proposal (Solicitation document) The National Institute of Mental Health (NIMH) is issuing a Request for Proposals (RFP) No. HHS-NIH-NIMH-10-024 entitled "Rapidly-Acting Treatments for Treatment-Resistant Depression (RAPID)" under Full and Open Competition. This is a Research and Development initiative which is anticipated to leverage the development of rapid treatments (demonstrable clinical improvement within 72 hours of administration) for severe, treatment-resistant depression. 1. The primary objectives of resultant contract(s) are: a. To establish a network of sites to study "Rapidly-Acting Treatments for Depression" (i.e. the "RAPID-network") that will focus on identifying and testing promising interventions (pharmacological and/or non-pharmacological) that produce a substantial anti-depressant effect within 72 hours of initial administration. b. To perform randomized clinical trials testing such promising interventions (other than Ketamine Hydrochloride or sleep deprivation (total or partial)) in a well-characterizedcohort of adult patients (age 18-60) diagnosed with treatment-resistant depression. 2. A secondary objective of resultant contract(s) would be: a. To further study and evaluate interventions that showed efficacy in a RAPID-network Proof of Concept trial in a larger clinical trial. Important Considerations: 1. The Contractor(s) are responsible for identifying, recommending, and accessing (if a 3rd party is involved) all interventions to be tested during the contract period. 2. In order to be competitive for an award, Offerors should propose, with the initial offer, a trial of promising intervention with a detailed protocol that the network would be capable of initiating without delay after the infrastructure is established and after gaining all regulatory approvals. 3. The Contractor(s) should either already have access to and permission to develop the intervention (from a 3rd party supplier, if applicable), or provide evidence that there would not be delay involved in conducting the 1st trial due to access problems. 4. The peer reviewed evaluation of the scientific merit of the 1st recommended intervention, and access to develop that intervention, will be an important factor in determining which Offerors may be awarded a contract. The Offeror should also have the capability to: 1. Perform clinical trials of both pharmacological and non-pharmacological interventions in treatment-resistant depression specifically. 2. Provide scientific oversight, facilitate collaboration among the investigators, integrate complex protocol management, data acquisition, bio-statistical data analysis and reporting of results from clinical trials involving subjects with treatment-resistant depression. 3. Collaborate with multiple experts and stakeholders (investigators, clinicians, advocates, and consumers) in treatment-resistant depression research. General Information: This RFP, HHS-NIH-NIMH-10-024, details the specifics of the project as well as information pertinent to the development of an Offeror's proposal. The solicitation document may be accessed through the Internet at the Federal Business Opportunities website at: http://www.fedbizopps.gov. No paper copies will be available. Offerors are responsible for downloading their own copy of the solicitation and amendments that may be issued by the Government. Proposals will be due on or about January 13, 2011. It is anticipated that one or more cost-reimbursement contract awards will be made for a period of five years beginning on or about June 30, 2011. Contract(s) will be Indefinite Delivery Indefinite Quantity (IDIQ) and the number of interventions to be tested over the contract period is indefinite beyond the 1st intervention. This modification/amendment to the Pre-solicitation notice HHSNIHNIMH10024 corresponds to the Small Business Sources Sought notice: #HHS-NIMH-SBSS-10-001 previously posted on August 11, 2010 and Research and Development Sources Sought notice#: HHSNIHNIMHRDSS10024 posted on September 16, 2010. All responsible sources are encouraged to submit a proposal that will be considered by the NIMH. This advertisement does not commit the Government to award a contract. Please contact Marla Jacobson, Contract Specialist at jacobsonmj@mail.nih.gov for further information. All questions must be submitted in writing to jacobsonmj@mail.nih.gov.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/HHSNIHNIMH10024/listing.html)
 
Place of Performance
Address: None specified, United States
 
Record
SN02334365-W 20101201/101129233802-a748afe505349c4821425bb5311f05bc (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.